(redirected from Adenomatous polyposis coli)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to Adenomatous polyposis coli: Familial adenomatous polyposis
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for APC

(military) an armored vehicle (usually equipped with caterpillar treads) that is used to transport infantry

a drug combination found in some over-the-counter headache remedies (aspirin and phenacetin and caffeine)

References in periodicals archive ?
Familial Adenomatous Polyposis Coli - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Global Markets Direct's, 'Familial Adenomatous Polyposis Coli - Pipeline Review, H1 2012', provides an overview of the Familial Adenomatous Polyposis Coli therapeutic pipeline.
We obtained DNA samples from patients with attenuated or classic adenomatous polyposis coli and no detectable APC germline mutations.
The company is seeking marketing approval of Aptosyn for the treatment of adenomatous polyposis coli ("APC"), a rare disease that puts those afflicted at high risk of developing colon cancer.
com/research/cc6c2e/familial_adenomato) has announced the addition of Global Markets Direct's new report "Familial Adenomatous Polyposis Coli - Pipeline Review, Q1 2011" to their offering.
Molecular diagnosis of familial adenomatous polyposis (FAP): genotyping of adenomatous polyposis coli (APC) alleles by MALDI-TOF mass spectrometry.
This autosomal-dominant disorder results from a mutation of the adenomatous polyposis coli (APC) gene and accounts for 1% of all colorectal cancer.
As proof of the principle, the researchers demonstrated the applicability of HRM for detection of promoter methylation using assays for O6-methylguanine-DNA methyltransferase (MGMT), adenomatous polyposis coli (APC), glutathione S-transferase P1 (GSTP1), and phosphatase and tension homolog deleted on chromosome 10 (PTEN) promoters in methylated DNA dilution matrix.
Eighty-five percent of colorectal cancers result from chromosomal instability, with acquired mutations progressively accumulating in the adenomatous polyposis coli (APC) and p53 tumor suppressor genes, and in the k-ras oncogene.
In colon cancer, excessive cell growth occurs as the result of the accumulation of a regulatory protein, beta-catenin, usually caused by mutations in the adenomatous polyposis coli (APC) gene.